These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14192012)

  • 1. [CLINICAL EXPERIENCES WITH A NEW SECRETOLYTIC (BISOLVON) BY USING SUBJECTIVE AND OBJECTIVE METHODS].
    GOEBEL P; GOEBEL-RIEKEN E
    Hippokrates; 1964 Mar; 35():194-8. PubMed ID: 14192012
    [No Abstract]   [Full Text] [Related]  

  • 2. [PRELIMINARY CLINICO-EXPERIMENTAL EXPERIENCES WITH BISOLVON, A MUCOLYTIC AGENT].
    BUERGI H
    Schweiz Med Wochenschr; 1965 Feb; 95():274-9. PubMed ID: 14256574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with the new secretolytic Bisolvon].
    Junge W; Günthner W; Haslreiter E; Hess K; Loos M
    Med Klin; 1965 Dec; 60(51):2058-61. PubMed ID: 5332371
    [No Abstract]   [Full Text] [Related]  

  • 4. A new mucolytic, bromhexine ("bisolvon"). A double-blind study.
    Bateman PP
    Med J Aust; 1971 May; 1(18):963-5. PubMed ID: 4930812
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICAL EVALUATION OF THE DRUG NA-274 IN NON-TUBERCULOUS RESPIRATORY PATHOLOGY].
    CONDEGARGOLLO E
    Med Clin (Barc); 1964 Feb; 42():93-100. PubMed ID: 14163692
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
    Rossini G
    Med Monatsschr; 1970 Jun; 24(6):270-2. PubMed ID: 5525114
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Influence of secretolytic agents on mucociliary clearance in bronchitics.
    Konietzko N; Auernhammer W; Kampmann H; Matthys H
    Bull Physiopathol Respir (Nancy); 1975; 11(2):145P-147P. PubMed ID: 1097009
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the bronchosecretolytic bisolvon (bromhexine) on the frequency of detection of U. tuberculosis and malignant cells in the sputum].
    Tomasić-Cvitanović S
    Lijec Vjesn; 1970; 92(8):941-4. PubMed ID: 4997374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secretolytic effect of sobrelol and improvement of pulmonary ventilation in patients with chronic pulmonary tuberculosis associated with chronic bronchitis].
    Bosisio E; Sergi M; Nunziante A; Baudin E
    G Ital Mal Torace; 1971; 25(3):145-61. PubMed ID: 5143403
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secretolytic bisolvon in the treatment of chronic bronchitis and bronchial asthma].
    Beritić T
    Lijec Vjesn; 1968; 90(8):775-9. PubMed ID: 4888799
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bisolvomycin and Bisolvon in the treatment of chronic bronchitis, bronchial asthma and bronchiectasis].
    Mijusković B; Macanović J
    Plucne Bolesti Tuberk; 1972; 24(3):229-33. PubMed ID: 4571639
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Effect of Bisolvon.
    Bamford TM
    Med J Aust; 1974 Jun; 1(23):943. PubMed ID: 4852767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term treatment of the bronchitis syndrome with combinations of a secretolytic agent (Bisolvon-Linctus, Bisulvonamide, Bisolvonmycin)].
    Görlach FW
    Hippokrates; 1969 Nov; 40(21):850-3. PubMed ID: 5382635
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML
    Med J Aust; 1976 Apr; 1(17):612,614-5,617. PubMed ID: 778563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synergistic action of sodium thiophencarboxylate and bromhexine in chronic bronchitis in rats].
    Badimón JJ; Escolar G; Martínez JC; Borruel MT; Villaverde CA
    Arch Farmacol Toxicol; 1981 Apr; 7(1):161-4. PubMed ID: 7325708
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues.
    Gibbs BF
    Int J Immunopathol Pharmacol; 2009; 22(4):919-27. PubMed ID: 20074455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
    Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
    J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of spasmolytic and secretolytic agents in therapy of pulmonary tuberculosis; aerosol therapy].
    UHDE H
    Tuberkulosearzt; 1956 Sep; 10(9):546-8. PubMed ID: 13391938
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with a new secretolytic drug.
    Villa R; Orlandini GC
    Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis as a cause of upper lobe bronchiectasis.
    SALKIN D
    Calif Med; 1950 Dec; 73(6):577-80. PubMed ID: 14792368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.